10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 328 filers reported holding 10X GENOMICS INC in Q3 2021. The put-call ratio across all filers is 2.03 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,500 | -26.1% | 400 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $22,336 | +0.1% | 400 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $22,316 | +53.1% | 400 | 0.0% | 0.01% | +66.7% |
| Q4 2022 | $14,576 | -81.3% | 400 | -85.5% | 0.00% | -81.2% |
| Q3 2022 | $78,000 | -40.5% | 2,755 | -4.7% | 0.02% | -33.3% |
| Q2 2022 | $131,000 | -41.5% | 2,890 | -2.0% | 0.02% | -31.4% |
| Q1 2022 | $224,000 | -48.7% | 2,950 | +0.5% | 0.04% | -47.8% |
| Q4 2021 | $437,000 | +0.9% | 2,935 | -1.3% | 0.07% | -5.6% |
| Q3 2021 | $433,000 | -30.2% | 2,975 | -6.0% | 0.07% | -30.4% |
| Q2 2021 | $620,000 | +5.3% | 3,165 | -2.8% | 0.10% | -2.9% |
| Q1 2021 | $589,000 | +34.2% | 3,255 | +5.0% | 0.10% | +23.5% |
| Q4 2020 | $439,000 | – | 3,100 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |